|
Market Closed -
London S.E.
11:35:18 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 113.80 GBX | -1.39% |
|
+1.07% | -8.96% |
| 09-09 | EARNINGS AND TRADING: Pebble Beach revenue grows as forecast | AN |
| 07-13 | PureTech Health announces first patient dosing in Celea phase 3 trial | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PURETECH HEALTH PLC | Other Biotechnology & Medical Research | -1.39% | +1.07% | -8.96% | -14.05% | -68.39% | 377M |  | | |
- Stock Market
- Stocks
- PRTC Stock
- Charts PureTech Health plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
